التفاصيل البيبلوغرافية
العنوان: |
Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy. |
المؤلفون: |
Zakeri, Kaveh, Wang, Huili, Kang, Jung Julie, Lee, Anna, Romesser, Paul, Mohamed, Nader, Gelblum, Daphna, Sherman, Eric, Dunn, Lara, Boyle, Jay, Wong, Richard, Chen, Linda, Yu, Yao, Tsai, C. Jillian, McBride, Sean M., Riaz, Nadeem, Lee, Nancy |
المصدر: |
Head & Neck; Apr2021, Vol. 43 Issue 4, p1056-1062, 7p |
مصطلحات موضوعية: |
PROGNOSIS, PROTON therapy, SALIVARY glands, SALIVARY gland cancer, ADENOID cystic carcinoma, PHOTON emission, PAROTID glands |
مستخلص: |
Background: Proton beam radiation therapy (PBRT) has dosimetric advantages compared to photon radiation therapy for the treatment of major salivary gland tumors (MSGTs). Methods: Patients with non‐metastatic MSGTs treated at a single proton therapy center from October 2013 to October 2018 were retrospectively reviewed. Results: Sixty‐eight patients with MSGTs were included and the most common site and histology were the parotid gland (75.0%) and adenoid cystic carcinoma (22.1%), respectively. The 3‐year rates of locoregional control, progression‐free survival, and overall survival were 95.1% (95% CI: 89.9%‐100.0%), 80.7% (70.2%‐92.7%), and 96.1% (95% CI: 90.9%‐100.0%), respectively. Conclusion: In a large cohort of MSGTs treated with PBRT, the rates of locoregional control were high in short‐term follow‐up and treatment was well tolerated. [ABSTRACT FROM AUTHOR] |
|
Copyright of Head & Neck is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |